Total pendapatan perusahaan OnKure Therapeutics (OKUR)

Simbol lan logo merek OnKure Therapeutics, Inc. (OKUR)

OnKure Therapeutics Inc (OKUR) gross sales levels demonstrate revenue dynamics, where the value 0.00 describes the current level. The business relies on the development of targeted inhibitors to combat solid tumors. The uniqueness of the OKI-179 molecule, which suppresses breast cancer mutations, provides high profit potential. However, a critical dependence on clinical trial results and the risk of liquidity shortages create serious financial threats.

OnKure - Pendapatan perusahaan OKUR (periode 08.10.2024 - 18.11.2026)

Rincian analitis perusahaan OnKure Therapeutics Inc

Ringkesan analisis perusahaan:OKUR (OnKure)
Barang utama OnKure Therapeutics Inc

This metric accumulates the value of all goods sold per day, reflecting the actual capital density within the asset. The trend of this metric depends directly on the frequency of operational reports and shipment volumes. Analyzing the gross sales revenue of OnKure Therapeutics Inc (OKUR) allows for an objective forecast of cash flows, excluding speculative expectations. For OnKure Therapeutics Inc (OKUR), such data confirms the commercial demand for their innovative inhibitors in the targeted oncology segment.

Perusahaan pesaing

Pendapatan perusahaan ONC|Pendapatan lan volume dodolan HALO|RVMD (Revolution Medicines, Inc.) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Ascentage Pharma Corp AAPG|Total volume dodolan perusahaan CG Oncology, Inc.|URGN - Pendapatan perusahaan|Bicara Therapeutics Inc. (BCAX) - Dodolan perusahaan|Personalis Inc (PSNL) - Pendapatan perusahaan|ERAS - Pendapatan reged perusahaan|DCTH (Delcath Systems Inc) - Pendapatan lan volume dodolan|Pendapatan perusahaan YMAB|Pendapatan lan volume dodolan AURA|Pendapatan perusahaan CADL (Candel)|Accuray, Inc. - Dodolan perusahaan|SELLAS Life Sciences Group Inc. - Pendapatan perusahaan|ACTU: Dodolan perusahaan|Total pendapatan perusahaan Citius Oncology Inc|HURA: Pendapatan lan volume dodolan|TARA: Total dodolan perusahaan|FATE (fatetherapeutics.com) - Pendapatan lan volume dodolan|Dodolan perusahaan Aadi Bioscience Inc (WHWK)|Pendapatan lan volume dodolan TCRX|CSBR - Total pendapatan perusahaan|Pendapatan lan volume dodolan XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Total pendapatan perusahaan|OSTX: Dodolan perusahaan|Pendapatan dodolan perusahaan RADX (Radiopharm Theranostics)|Artiva (ARTV) - Pendapatan perusahaan|ANL: Total dodolan perusahaan|VERU (Veru Corporation) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Tempest Therapeutics, Inc. TPST|Pendapatan lan volume dodolan XLO|Renovaro - Volume dodolan perusahaan|Pendapatan perusahaan Mural Bio MURA|KAPA: Volume dodolan perusahaan|CytoMed Therapeutics Ltd - Pendapatan lan volume dodolan|curis.com (CRIS) - Dodolan perusahaan|Apollomics Corp (APLM) - Pendapatan perusahaan|Tharimmune - Pendapatan dodolan perusahaan|ADVB (Advanced Biomed Corp) - Pendapatan lan volume dodolan|Dodolan perusahaan Genprex, Inc (GNPX)|Pendapatan lan volume dodolan CLDI|SBFM: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan XBIO (xeneticbio.com)|Pendapatan lan volume dodolan Salarius Pharmaceuticals Inc SLRX|purple-biotech.com - Pendapatan lan volume dodolan|Total pendapatan perusahaan American Oncology Network, Inc.|BGNE: Pendapatan lan volume dodolan|Dodolan perusahaan checkpointtx.com|Pendapatan perusahaan Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Pendapatan reged perusahaan|Pendapatan perusahaan Ikena (IKNA)|NTBL - Total pendapatan perusahaan|Pendapatan perusahaan viracta.com VIRX|morphosys.com (MOR) - Total pendapatan perusahaan|NAYA Biosciences Inc - Pendapatan lan volume dodolan|AAPGV: Pendapatan perusahaan